止血
止血剂
医学
叙述性评论
纤维蛋白
凝结
止血剂
重症监护医学
血小板
外科
免疫学
内科学
作者
Yuting Zhong,Huayu Hu,Ningning Min,Yufan Wei,Xiangdong Li,Xiru Li
出处
期刊:Annals of Translational Medicine
[AME Publishing Company]
日期:2021-04-01
卷期号:9 (7): 577-577
被引量:71
摘要
Abstract: Bleeding complications can cause significant morbidities and mortalities in both civilian and military conditions. The formation of stable blood clots or hemostasis is essential to prevent major blood loss and death from excessive bleeding. However, the body's self-coagulation process cannot accomplish timely hemostasis without the assistance of hemostatic agents under some conditions. In the past two decades, topical hemostatic materials and devices containing platelets, fibrin, and polysaccharides have been gradually developed and introduced to induce faster or more stable blood clot formation, updating or iterating traditional hemostatic materials. Despite the various forms and functions of topical hemostatic materials that have been developed for different clinical conditions, uncontrolled hemorrhage still causes over 30% of trauma deaths across the world. Therefore, it is important to fabricate fast, efficient, safe, and ready-to-use novel hemostatic materials. It is necessary to understand the coagulation process and the hemostatic mechanism of different materials to develop novel topical hemostatic agents, such as tissue adhesives and sealants from various natural and synthetic materials. This review discusses the structural features of topical hemostatic materials related to the stimulation of hemostasis, summarizes the commercially available products and their applications, and reviews the ongoing clinical trials and recent studies concerning the development of different hemostatic materials.
科研通智能强力驱动
Strongly Powered by AbleSci AI